Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer and BioImage to Co-Develop Cell-Based Screening Offering

NEW YORK, Aug. 25 (GenomeWeb News) - PerkinElmer will collaborate with Danish drug discovery firm BioImage to develop cell-based assays for drug screening, PerkinElmer said today.

 

Under the terms of the agreement, the companies will combine BioImage's assay methods and reagents for measuring protein-protein interactions with PerkinElmer's Envision fluorometric detection instrument. PerkinElmer said that BioImage, based in Copenhagen, has already developed a suite of assays to be used on the Envision platform.

 

Financial terms of the deal were not disclosed.